IgG Cleaving Enzymes as a Potential Solution to the NAb Challenge
Time: 1:00 pm
day: Day 1 Track B PM
Details:
- An overview of Imlifidase: it’s MOA and translatability for use in conjunction with gene therapies
- Analyzing data from its use in in-human gene therapy trials
- Considerations for treatment timing and dosing post-adminstration
